Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Aukera Inc
Profile last edited on: 2/18/20      CAGE: 7M2Y9      UEI: MWL1B1VKMCB4

Business Identifier: Platform to encapsulate a vaccine targeting immune system to attack the cancer cells
Year Founded
2016
First Award
2019
Latest Award
2019
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2265 East Foothill Boulevard
Pasadena, CA 91107
   N/A
   N/A
   www.aukerasolutions.com
Location: Single
Congr. District: 27
County: Los Angeles

Public Profile

Anchored in a proprietary 3D nanoprinting methodology, Aukera, Inc. specializes in the development, research, and production of unique, protein-based nanocapsules. By employing proprietary nCap™ technology the firms' nanocapsule products can be used safely to deliver therapeutic molecule

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$299,979
Phase II Dollars
$0
Total Awarded
$299,979

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 1 NIH $299,979
Project Title: Development of a Vault Nanovaccine for Pancreatic Cancer Immunotherapy

Key People / Management

  Gayle Boxx -- Founder, & Chief Executive Officer

  Jan Mrazek -- Founder and Chief Scientific Officer

Company News

There are no news available.